CD4 and peripheral arterial disease: Moreover, PBMC stimulation with SARS-CoV-2 NCAP peptide pool elucidated higher frequencies of antigen specific CD4+ T cells in 4/4 PAD patients compared to CHC (p = 0.03) and also in CHC compared to naïve HC (p = 0.04) (Figure 1A).